Epidemiology of Malignant Melanoma
暂无分享,去创建一个
[1] J. Kładny,et al. Common variants of DNA repair genes and malignant melanoma. , 2008, European journal of cancer.
[2] Claus Garbe,et al. The incidence and mortality of cutaneous melanoma in southern Germany , 2006, Cancer.
[3] P. Duray,et al. Neonatal sunburn and melanoma in mice , 2001, Nature.
[4] J. Barrett,et al. The effect of sun exposure in determining nevus density in UK adolescent twins. , 2005, The Journal of investigative dermatology.
[5] Stephen B Gruber,et al. BRAF and NRAS mutations in melanoma and melanocytic nevi , 2006, Melanoma research.
[6] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.
[7] Lancaster Ho,et al. Some geographical aspects of the mortality from melanoma in Europeans. , 1956 .
[8] J. Wikberg,et al. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.
[9] D. English,et al. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? , 1995, Journal of the American Academy of Dermatology.
[10] R. Millikan,et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. , 2006, Carcinogenesis.
[11] K. Kraemer. Sunlight and skin cancer: another link revealed. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Verbeek,et al. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. , 1995, Journal of clinical epidemiology.
[13] S. Franceschi,et al. Risk of cutaneous melanoma associated with a family history of the disease , 1995, International journal of cancer.
[14] H. Olsson,et al. Cutaneous malignant melanoma in South Sweden 1965, 1975, and 1985. A histopathologic review , 1994, Cancer.
[15] V. Siskind,et al. Naevi in schoolchildren in Scotland and Australia , 1994, The British journal of dermatology.
[16] V. Siskind,et al. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[17] M. Tucker. Is Sunlight Important to Melanoma Causation? , 2008, Cancer Epidemiology Biomarkers & Prevention.
[18] A. Green,et al. A theory of site distribution of melanomas: Queensland, Australia , 1992, Cancer Causes & Control.
[19] D. Pinkel,et al. MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma , 2006, Science.
[20] J. Fraser,et al. Migration and death from malignant melanoma , 1985, International journal of cancer.
[21] J. Barrett,et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. , 2001, The Journal of investigative dermatology.
[22] J. Lundeberg,et al. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing , 2006, Melanoma research.
[23] Y. Huang,et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk , 2008, Journal of Human Genetics.
[24] L. Naldi,et al. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. , 2006, The Journal of investigative dermatology.
[25] Renato Panizzon,et al. Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case‐control study of the german central malignant‐melanoma registry , 1995, International journal of cancer.
[26] V. Siskind,et al. MOLES IN AUSTRALIAN AND BRITISH SCHOOLCHILDREN , 1988, The Lancet.
[27] N. Thomas. BRAF somatic mutations in malignant melanoma and melanocytic naevi , 2006, Melanoma research.
[28] J. Bulliard,et al. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. , 2000, International journal of epidemiology.
[29] M. Viola,et al. Malignant melanoma in Connecticut and Denmark , 1980, International journal of cancer.
[30] K. Hou‐Jensen,et al. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. , 1988, British Journal of Cancer.
[31] F. Sera,et al. MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.
[32] R. Millikan,et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. , 2005, Journal of the National Cancer Institute.
[33] Lisa M. Schwartz,et al. Skin biopsy rates and incidence of melanoma: population based ecological study , 2005, BMJ : British Medical Journal.
[34] Z. Zhuang,et al. The PTEN tumour suppressor gene and malignant melanoma , 1998, Melanoma research.
[35] J. Elwood,et al. Cutaneous melanoma in relation to intermittent and constant sun exposure—the western canada melanoma study , 1985, International journal of cancer.
[36] R. Gallagher,et al. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.
[37] R. Winkelmann,et al. Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. , 1990, Mayo Clinic proceedings.
[38] S. Harrison,et al. Sun exposure and melanocytic naevi in young Australian children , 1994, The Lancet.
[39] A. Baccarelli,et al. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk , 2004, British Journal of Cancer.
[40] R. MacKie,et al. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. , 2005, The Journal of investigative dermatology.
[41] G. Colditz,et al. Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.
[42] T. Holford,et al. Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.
[43] D. Bishop,et al. Germline mutations of the CDKN2 gene in UK melanoma families. , 1997, Human molecular genetics.
[44] K. Magnus. Habits of sun exposure and risk of malignant melanoma: An analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary tumor site , 1981, Cancer.
[45] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[46] Ian Jackson,et al. Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.
[47] M. Coory,et al. Trends in melanoma mortality in Australia: 1950–2002 and their implications for melanoma control , 2005, Australian and New Zealand journal of public health.
[48] D. Whiteman,et al. p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.
[49] R. Gallagher. Sunbeds--do they increase risk of melanoma or not? , 2005, European journal of cancer.
[50] J. Bulliard. Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.
[51] R. Hofmann-Wellenhof,et al. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis , 2002, Melanoma research.
[52] M. Cattaruzza,et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. , 1998, Journal of the National Cancer Institute.
[53] C. Garbe,et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. , 1992, Journal of the American Academy of Dermatology.
[54] G. Peters. Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma. , 2008, Journal of the National Cancer Institute.
[55] A. Green,et al. Cutaneous malignant melanoma in association with other skin cancers. , 1985, Journal of the National Cancer Institute.
[56] R. Gallagher,et al. Etiologic and Other Factors Predicting Nevus-Associated Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.
[57] F. Bray,et al. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[58] A. Dobson,et al. Mortality from malignant melanoma in Australia: effects due to country of birth. , 1982, International journal of epidemiology.
[59] M. Tucker,et al. The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.
[60] V. Giannotti,et al. Spatial association of melanocytic naevus and melanoma , 1991, Melanoma research.
[61] I. Jackson,et al. Melanocortin 1 receptor variants in an Irish population. , 1998, The Journal of investigative dermatology.
[62] D. Whiteman,et al. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies , 2004, Cancer Causes & Control.
[63] J. Aitken,et al. Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.
[64] Ajay N. Jain,et al. Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.
[65] G. Giles,et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.
[66] Q. Wei,et al. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non‐Hispanic whites in Texas: A case–control study , 2008, International journal of cancer.
[67] D. Pinkel,et al. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. , 2007, The Journal of investigative dermatology.
[68] Exposure to Artificial Ultraviolet Light. Meeting. Exposure to artificial UV radiation and skin cancer , 2006 .
[69] A. Green,et al. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. , 1992, American journal of epidemiology.
[70] A. Basten,et al. SCLERODERMA IN CARCINOMA , 1966, The Medical journal of Australia.
[71] Tim K. Lee,et al. Tanning Beds, Sunlamps, and Risk of Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.
[72] M. Skolnick,et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. , 1992, Science.
[73] D. Whiteman,et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] R. Millikan,et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[75] Florence Demenais,et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.
[76] M. Berwick,et al. Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program. , 2008, The Journal of investigative dermatology.
[77] W. Lambert,et al. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. , 1994, Archives of dermatology.
[78] J. Rees,et al. The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation , 2005, Peptides.
[79] H. Gogas,et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. , 2006, The Journal of investigative dermatology.
[80] J. Mark Elwood,et al. Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.
[81] L. Naldi,et al. Sun Exposure, Phenotypic Characteristics, and Cutaneous Malignant Melanoma. An Analysis According to Different Clinico-Pathological Variants and Anatomic Locations (Italy) , 2005, Cancer Causes & Control.
[82] R. MacKie,et al. Cutaneous malignant melanoma, Scotland, 1979-89 , 1992, The Lancet.
[83] M. Berwick,et al. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.
[84] H. Nelson,et al. SUNLIGHT AS A CAUSE OF MELANOMA: A CLINICAL SURVEY , 1957, Medical Journal of Australia.
[85] A Biggeri,et al. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. , 1999, Journal of the American Academy of Dermatology.
[86] A. Jemal,et al. Recent trends in cutaneous melanoma incidence among whites in the United States. , 2001, Journal of the National Cancer Institute.
[87] J. Coebergh,et al. Cutaneous malignant melanoma in Europe. , 2004, European journal of cancer.
[88] N. Hayward,et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.
[89] V. Siskind,et al. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 , 2007, Cancer Causes & Control.
[90] S. Harrison,et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. , 1994, Journal of the American Academy of Dermatology.
[91] P. Hersey,et al. An analysis of a melanoma epidemic , 1993, International journal of cancer.
[92] S. Shuster. Is sun exposure a major cause of melanoma? No , 2008, BMJ : British Medical Journal.
[93] W. Willett,et al. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. , 1989, Journal of the National Cancer Institute.
[94] Arjun Chanmugam,et al. Cutaneous malignant melanoma. , 2006, Mayo Clinic proceedings.
[95] C. Garbe,et al. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe , 2000, Cancer.
[96] B K Armstrong,et al. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? , 1988, The Journal of dermatologic surgery and oncology.
[97] B. Armstrong,et al. How much melanoma is caused by sun exposure? , 1993, Melanoma research.
[98] F. Bray,et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.
[99] D. Duffy,et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. , 1999, Journal of the National Cancer Institute.
[100] J. J. van den Oord,et al. p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant: a clue to their divergent pathogenesis? , 2004, Melanoma research.
[101] J. Weber,et al. Confirmation of chromosome 9p linkage in familial melanoma. , 1993, American journal of human genetics.
[102] A. Stang,et al. Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. , 2003, European journal of cancer.
[103] M. Trivett,et al. Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. , 2007, The Journal of investigative dermatology.
[104] J Cuzick,et al. Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.
[105] N. Martin,et al. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.
[106] D. Easton,et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .
[107] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.
[108] J. Rivers. Is there more than one road to melanoma? , 2004, The Lancet.
[109] I. Crombie. Variation of melanoma incidence with latitude in North America and Europe. , 1979, British Journal of Cancer.
[110] C. UNG‐JUURLINK. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma. , 1999, Journal of the American Academy of Dermatology.
[111] J F Aitken,et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.
[112] E. Wynder,et al. The "over-exposed" control group. , 1992, American journal of epidemiology.
[113] J. Spinelli,et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. , 1990, Archives of dermatology.
[114] B. Armstrong,et al. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.
[115] P. Boyle,et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. , 2005, European journal of cancer.
[116] J. Gulcher,et al. CDKN2A mutations and melanoma risk in the Icelandic population , 2008, Journal of Medical Genetics.
[117] G. Colditz,et al. Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[118] C. Garbe,et al. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood , 2003, Cancer.
[119] T. Holford,et al. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site , 1994, Cancer Causes & Control.
[120] C. la Vecchia,et al. Incidence of invasive cancers following squamous cell skin cancer. , 1997, American journal of epidemiology.
[121] P. Hull,et al. Trends in Invasive Cutaneous Melanoma in Saskatchewan 1970–1999 , 2003, Journal of cutaneous medicine and surgery.
[122] D. English,et al. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. , 1994, American journal of epidemiology.
[123] J. Bulliard,et al. Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[124] K. Magnus. Incidence of malignant melanoma of the skin in Norway, 1955–1970. Variations in time and space and solar radiation , 1973, Cancer.
[125] M. Pollán,et al. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women , 2008, The British journal of dermatology.
[126] Harry L. Arnold,et al. American Academy of Dermatology , 1980 .
[127] R. Marks,et al. DO ALL MELANOMAS COME FROM “MOLES”? A STUDY OF THE HISTOLOGICAL ASSOCIATION BETWEEN MELANOCYTIC NAEVI AND MELANOMA , 1990, The Australasian journal of dermatology.
[128] J. Bulliard,et al. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand , 1994, Cancer Causes & Control.
[129] N. Martin,et al. Site distribution of cutaneous melanoma in queensland , 1993, International journal of cancer.
[130] M. Nicolson,et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study , 2002, The Lancet.
[131] Sikandar G. Khan,et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. , 2005, Carcinogenesis.
[132] A. Stang,et al. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases , 2006, International journal of cancer.
[133] Sikandar G. Khan,et al. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma , 2005, European Journal of Human Genetics.
[134] D. Housman,et al. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). , 1993, American journal of human genetics.
[135] L. Sandkuijl,et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.
[136] D. Whiteman,et al. Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. , 2011, Journal of the American Academy of Dermatology.
[137] A. Jemal,et al. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. , 2000, Journal of the National Cancer Institute.
[138] Forbes Ja. Infectious diseases, today and tomorrow. , 1966 .
[139] D. Lipsker,et al. Trends in melanoma epidemiology suggest three different types of melanoma , 2007, The British journal of dermatology.
[140] T. Dwyer,et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? , 2004, American journal of epidemiology.
[141] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[142] R. Burton,et al. Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.
[143] P. Autier,et al. Influence of sun exposures during childhood and during adulthood on melanoma risk , 1998, International journal of cancer.